Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Minoxidil and finasteride treat hair loss; more research needed for other options.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Targeting hair follicles can improve skin treatments and reduce side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Thicker hair grows faster; hair loss patients have slower growth.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

New treatments for hair loss are being developed using molecular biology.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

The compounds tested could potentially treat hair loss and alopecia.

DHT, a testosterone byproduct, causes male pattern baldness.